Table 2

Clinical characteristics of infants diagnosed with cCMV infection

CaseGenderMaternal CMV infection typeTrimester of maternal infectionSuspicion during pregnancySign/s at birth other than refer hearing screeningSaliva screening taken dayUrine
screening taken day
Hearing status at diagnosisAge at start of antiviral treatment, weeks
1MNon-primaryUnknownNoNo310Bilateral mild to moderate SNHL5
2FPrimary2Maternal seroconversionNo13Within normal range12*
3FPrimary1Maternal seroconversionPetechiae, LSV, germinal matrix cyst, SGA, symmetric IUGR26Bilateral profound SNHL2
4FNon-primaryUnknownNoLSV, germinal matrix cysts35Bilateral profound SNHL2
  • *Valganciclovir treatment initiated due to developmental delay.

  • cCMV, congenital cytomegalovirus; F, female; IUGR, intrauterine growth restriction; LSV, lenticulostriate vasculopathy; M, male; SGA, small for gestational age; SNHL, sensorineural hearing loss.